Anthracyclines during pregnancy: embryo–fetal outcome in 160 patients
نویسندگان
چکیده
منابع مشابه
Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients.
BACKGROUND Anthracyclines are essential for the treatment of malignancies observed in pregnant patients. Knowledge of the potential side-effects of chemotherapy on the developing fetus is essential for patient counseling. PATIENTS AND METHODS We collected information concerning patients treated with anthracyclines during pregnancy from a review of literature between 1976 and 2001 and our expe...
متن کاملAnthracyclines for gestational breast cancer: course and outcome of pregnancy.
Gestational breast cancer (GBC) is a rare disease characterised by an aggressive clinical and biological behaviour [1]. In selected GBC patients, the administration of anthracycline-based regimens was shown to improve outcome [1]; however, the safety of this approach remains of concern. Here, we report the effects of anthracycline-based regimens on the course and outcome of pregnancy in patient...
متن کاملPregnancy and Cardiomyopathy After Anthracyclines in Childhood
With advances in cancer therapy, there has been a remarkable increase in survival in children diagnosed with malignancies. Many of these children are treated with anthracyclines which are well known to cause cardiotoxicity. As more childhood cancer survivors reach childbearing age, many will choose to become pregnant. At this time, the factors associated with development of cardiomyopathy after...
متن کاملWeight Gain During Pregnancy and Birth Weight Outcome In Pregnant Women, Tabriz, Iran
Introduction: The aim of this study was to investigate weight gain during pregnancy and birth weight in rural regions of Tabriz, a province in the northwest of Iran. Materials & Methods: A cross-sectional study was conducted using routinely collected data of pregnant mothers from rural health centers. Eight health centers were randomly selected in rural areas of Tabriz. Totally, 874 women aged...
متن کاملLong-term evaluation of cardiac function in children who received anthracyclines during pregnancy.
BACKGROUND The use of anthracyclines in patients with cancer has been associated with the presence, even when standard doses were employed, of cardiac toxicity, most frequently after 5 years of therapy. Treatment of cancer during pregnancy remains a dilemma because cytotoxic therapy has been associated with the presence of severe side-effects. The outcome of children that received antracyclines...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Oncology
سال: 2004
ISSN: 0923-7534
DOI: 10.1093/annonc/mdh009